Decreased histamine H1 receptor binding in the brain of depressed patients. 2004

Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
Department of Behavioural Medicine, Tohoku University School of Medicine, Sendai 980-8575, Japan.

The central histaminergic neuron system modulates the wakefulness, sleep-awake cycle, appetite control, learning and memory, and emotion. Previous studies have reported changes in neuronal histamine release and its metabolism under stress conditions in the mammalian brain. In this study, we examined, using positron emission tomography (PET) and [(11)C]-doxepin, whether the histaminergic neuron system is involved in human depression. Cerebral histamine H1 receptor (H(1)R) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and [(11)C]-doxepin. Data were calculated by a graphical analysis on voxel-by-voxel and ROI (region of interests) basis. Binding potential (BP) values for [(11)C]-doxepin binding in the frontal and prefrontal cortices, and cingulate gyrus were significantly lower in the depressed patients than those in the normal control subjects. There was no area of the brain where [(11)C]-doxepin binding was significantly higher in the depressed patients than in the controls. ROI-based analysis also revealed that BP values for [(11)C]-doxepin binding in the frontal cortex and cingulate gyrus decreased in proportion to self-rating depressive scales scores. The results of this study demonstrate that depressed patients have decreased brain H(1)R binding and that this decrease correlates with the severity of depression symptoms. It is therefore suggested that the histaminergic neuron system plays an important role in the pathophysiology of depression and that its modulation may prove to be useful in the treatment of depression.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011969 Receptors, Histamine H1 A class of histamine receptors discriminated by their pharmacology and mode of action. Most histamine H1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. (From Biochem Soc Trans 1992 Feb;20(1):122-5) H1 Receptor,Histamine H1 Receptors,H1 Receptors,Histamine H1 Receptor,Receptors, H1,H1 Receptor, Histamine,H1 Receptors, Histamine,Receptor, H1,Receptor, Histamine H1
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001931 Brain Mapping Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures. Brain Electrical Activity Mapping,Functional Cerebral Localization,Topographic Brain Mapping,Brain Mapping, Topographic,Functional Cerebral Localizations,Mapping, Brain,Mapping, Topographic Brain
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004316 Doxepin A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. Apo-Doxepin,Aponal,Deptran,Desidox,Doneurin,Doxepia,Doxepin Hydrochloride,Doxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5),Doxepin beta,Doxepin-RPh,Espadox,Mareen,Novo-Doxepin,Prudoxin,Quitaxon,Sinequan,Sinquan,Xepin,Zonalon,Apo Doxepin,ApoDoxepin,Doxepin RPh,Hydrochloride, Doxepin,Novo Doxepin

Related Publications

Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
June 1980, Journal of neurochemistry,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
April 2005, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
February 1994, The Journal of pharmacology and experimental therapeutics,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
July 2005, Nature chemical biology,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
January 1993, General pharmacology,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
May 2024, The Journal of comparative neurology,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
August 1990, Neuroscience letters,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
March 1998, European journal of pharmacology,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
March 2004, European journal of pharmacology,
Michiko Kano, and Shin Fukudo, and Atshushi Tashiro, and Atshushi Utsumi, and Daisaku Tamura, and Masatoshi Itoh, and Ren Iwata, and Manabu Tashiro, and Hideki Mochizuki, and Yoshihito Funaki, and Motohisa Kato, and Michio Hongo, and Kazuhiko Yanai
May 1980, Brain research,
Copied contents to your clipboard!